Phase IB study of the EpCAM antibody adecatumumab combined with docetaxel in patients with EpCAM-positive relapsed or refractory advanced-stage breast cancer von Schmidt, M., Rüttinger, D., Sebastian, M., Hanusch, C.A., Marschner, N., Baeuerle, P.A., Wolf, A., Göppel, G., Oruzio, D., Schlimok, G., Steger, G.G., Wolf, C., Eiermann, W., Lang, A., Schuler, M.

Volltext

Lapatinib versus trastuzumab in combination with neoadjuvant anthracycline-taxane-based chemotherapy (GeparQuinto, GBG 44): a randomised phase 3 trial von Untch, Michael, Prof, Loibl, Sibylle, MD, Bischoff, Joachim, MD, Eidtmann, Holger, MD, Kaufmann, Manfred, Prof, Blohmer, Jens-Uwe, Prof, Hilfrich, Jörn, Prof, Strumberg, Dirk, Prof, Fasching, Peter A, Prof, Kreienberg, Rolf, Prof, Tesch, Hans, Prof, Hanusch, Claus, MD, Gerber, Bernd, Prof, Rezai, Mahdi, MD, Jackisch, Christian, Prof, Huober, Jens, Prof, Kühn, Thorsten, Prof, Nekljudova, Valentina, PhD, von Minckwitz, Gunter, Prof

Volltext

Ten-year analysis of the prospective multicentre Chemo-N0 trial validates American Society of Clinical Oncology (ASCO)-recommended biomarkers uPA and PAI-1 for therapy decision mak... von Harbeck, N, Schmitt, M, Meisner, C, Friedel, C, Untch, M, Schmidt, M, Sweep, C.G.J, Lisboa, B.W, Lux, M.P, Beck, T, Hasmüller, S, Kiechle, M, Jänicke, F, Thomssen, C

Volltext

Survival after neoadjuvant chemotherapy with or without bevacizumab or everolimus for HER2-negative primary breast cancer (GBG 44–GeparQuinto) von von Minckwitz, G., Fasching, P.A., Schrader, I., Kittel, K., Huober, J., Solbach, C., Jackisch, C., Blohmer, J.U., Nekljudova, V., Gerber, B., Groh, U., Villena, C., Liedtke, B., Kittel, K., Mau, C., Potenberg, J., Schilling, J., Just, M., Bückner, U., Doering, G., Feidicker, S., Krabisch, P., Augustin, D., Nestle-Krämling, C., Rezai, M., Höß, C., Terhaag, J., Fasching, P., Staib, P., Aktas, B., Kühn, T., Khandan, F., Möbus, V., Solbach, C., Tesch, H., Stickeler, E., Heinrich, G., Wagner, H., Abdallah, A., Dewitz, T., Emons, G., Belau, A., Rethwisch, V., Lantzsch, T., Müller, V., Holms, F., Müller, T., Deuker, J.-U., Solomayer, E., Runnebaum, I., Link, H., Conrad, B., Feisel-Schwickardi, G., Steinmetz, T., Langanke, D., Ober, A., Fischer, D., Kohls, A., Weikel, W., Bischoff, J., Freese, K., Wiest, W., Sütterlin, M., Dietrich, M., Grießhammer, M., Burgmann, D.-M., Hanusch, C., Rack, B., Salat, C., Sattler, D., Tio, J., Christensen, B., Burkamp, U., Köhne, C.-H., Meinerz, W., Graßhoff, S.-T., Decker, T., Thalmann, I., Sallmann, A., Beck, T., Reimer, T., Bartzke, G., Deryal, M., Weigel, M., Huober, J., Steffens, C.-C., Lemster, S., Stefek, A., Ruhland, F., Hofmann, M., Schuster, J., Clemens, M., Fehm, T., Janni, W., Latos, K., Bauer, W., Roßmann, A., Bauer, L., Hoffmann, G., Schlag, R.

Volltext

Differences in human papillomavirus type distribution in high‐grade cervical intraepithelial neoplasia and invasive cervical cancer in Europe von Tjalma, Wiebren A., Fiander, Alison, Reich, Olaf, Powell, Ned, Nowakowski, Andrzej M., Kirschner, Benny, Koiss, Robert, O'Leary, John, Joura, Elmar A., Rosenlund, Mats, Colau, Brigitte, Schledermann, Doris, Kukk, Kersti, Damaskou, Vasileia, Repanti, Maria, Vladareanu, Radu, Kolomiets, Larisa, Savicheva, Alevtina, Shipitsyna, Elena, Ordi, Jaume, Molijn, Anco, Quint, Wim, Raillard, Alice, Rosillon, Dominique, De Souza, Sabrina Collas, Jenkins, David, Holl, Katsiaryna

Volltext

Abstract P2-08-01: Factors predicting relapse in early breast cancer patients with a pathological complete response after neoadjuvant therapy – Results of a pooled analysis based o... von Huober, J, Schneeweiss, A, Blohmer, J-U, Denkert, C, Tesch, H, Hanusch, CA, Salat, C, Rhiem, K, Rezai, M, Solbach, C, Fasching, PA, Jackisch, C, Mehta, K, Nekljudova, V, Seither, F, von Minckwitz, G, Loibl, S, Untch, M

Volltext

Abstract P4-06-01: Immunomonitoring of triple negative breast cancer patients undergoing neoadjuvant therapy with durvalumab - Results from the prospectively randomized GeparNuevo... von Massa, C, Schneeweiss, A, Karn, T, Hanusch, CA, Blohmer, J-U, Fasching, PA, Jackisch, C, van Mackelenbergh, M, Marmé, F, Müller, V, Schem, C, Stickeler, E, Huober, J, Weber, KE, Untch, M, Denkert, C, Loibl, S, Mueller, A, Biehl, K, Seliger, B

Volltext

Abstract PD5-05: Pre-therapeutic PD-L1 expression and dynamics of Ki-67 and gene expression during neoadjuvant immune-checkpoint blockade and chemotherapy to predict response withi... von Sinn, BV, Loibl, S, Karn, T, Untch, M, Kunze, CA, Weber, KE, Treue, D, Wagner, K, Hanusch, CA, Klauschen, F, Fasching, PA, Huober, J, Zahm, D-M, Jackisch, C, Thomalla, J, Blohmer, J-U, van Mackelenbergh, M, Rhiem, K, Felder, B, von Minckwitz, G, Burchardi, N, Schneeweiss, A, Denkert, C

Volltext

Abstract PD2-07: mRNA signatures predict response to durvalumab therapy in triple negative breast cancer (TNBC)– Results of the translational biomarker programme of the neoadjuvant... von Loibl, S, Sinn, BV, Karn, T, Untch, M, Treue, D, Sinn, H-P, Weber, KE, Hanusch, CA, Fasching, PA, Huober, J, Zahm, D-M, Jackisch, C, Thomalla, J, Blohmer, J-U, Marmé, F, Klauschen, F, Rhiem, K, Felder, B, von Minckwitz, G, Burchardi, N, Schneeweiss, A, Denkert, C

Volltext

Neoadjuvant bevacizumab and anthracycline–taxane-based chemotherapry in 686 triple-negative primary breast cancers: Seconday endpoint analysis of the GeparQuinto study (GBG 44) von Gerber, B., Eidtmann, H., Rezai, M., Fasching, P. A., Tesch, H., Eggemann, H., Schrader, I., Kittel, K., Hanusch, C. A., Kreienberg, R., Solbach, C., Jackisch, C., Kunz, G., Blohmer, J. U., Huober, J. B., Hauschild, M., Loibl, S., Nekljudova, V., Untch, M., Von Minckwitz, G.

Volltext

Correlation of various pathologic complete response (pCR) definitions with long-term outcome and the prognostic value of pCR in various breast cancer subtypes: Results from the Ger... von Von Minckwitz, G., Kaufmann, M., Kuemmel, S., Fasching, P. A., Eiermann, W., Blohmer, J. U., Costa, S. D., Hilfrich, J., Jackisch, C., Gerber, B., Du Bois, A., Huober, J. B., Hanusch, C. A., Konecny, G. E., Fett, W., Stickeler, E., Harbeck, N., Mehta, K., Loibl, S., Untch, M.

Volltext

Phase IB study of the EpCAM antibody adecatumumab combined with docetaxel in patients with EpCAM-positive relapsed or refractory advanced-stage breast cancer von Schmidt, M, Rüttinger, D, Sebastian, M, Hanusch, C A, Marschner, N, Baeuerle, P A, Wolf, A, Göppel, G, Oruzio, D, Schlimok, G, Steger, G G, Wolf, C, Eiermann, W, Lang, A, Schuler, M

Volltext

Fracture fixation in the operative management of hip fractures (FAITH): an international, multicentre, randomised controlled trial von Oatt, Amber, Karlsten, Anders, Marcantonio, Andrew J., Rai, Anil, Zurcher, Arthur W., Jain, Arvind, Hileman, Barbara, Verhoeven, Bart, Fioole, Bram, Richardson, C. Glen, Bowler, Carol, Humphrey, Catherine A., Koppert, Cees L., DePaolo, Charles J., Anderson, Christopher G., van der Hart, Cor P., Stinner, Daniel, Viskontas, Darius, Karges, David E., Johnston, David, Yen, David, Olakkengil, Davy J, Donegan, Derek, Nam, Diane, Li, Doug, Tan, Edward T.C.H., Schemitsch, Emil H., Hammacher, Eric R., Torres, Erick T., Howells, Fiona, Gudger, Garland K., Wood, Gavin, Hjorthaug, Geir, Rieser, Geoffrey Ryan, Chuter, Graham, Rocca, Gregory J. Della, Dobbin, Gwendolyn, Kuiken, Hans, Rijna, Herman, Rajakumar, Janakiraman, Baker, Janell K., de Vries, Jean Paul P.M., May, Jedediah, Hoffman, Jodi M., Cherian, Joe Joseph, Clarke-Jenssen, John, Adams, John D., Gorczyca, John T., Foret, Jonathan L., Keeve, Jonathan P., Scheepers, Joris J.G., Baele, Joseph, Cass, Joseph R., Turckan, Kahn, Rai, Kamal, van Wessem, Karlijn, Kruse, Kevin K., Browner, Kieran, Lyle, Lindsey, Pilling, Lindsey, Buckingham, Lisa, de Waal Malefijt, Maarten C., Bronkhorst, Maarten W.G.A., Lobo, Margaret J., Swinton, Marilyn, Tynan, Martin C., Heetveld, Martin J., Esser, Max, Peters, Melissa E., Dunbar, Michael, Beckish, Michael L., Brennan, Michael L., Kain, Michael S.H., Vogt, Michelle, Bruijninckx, Milko M.M., Palla, Naveen, Schep, Niels W.L., Seuffert, Patricia, Zalzal, Paul, Kregor, Philip, Oprel, Pim, Snider, Rebecca G., Farrugia, Richard J, Korley, Robert, Probe, Robert, Wessel, Ronald N., Miller, Russell, Finnan, Ryan, Puloski, Shannon, Zielinski, Stephanie M., Papp, Steve, Hollenbeck, Steven M., Weinerman, Stuart, Lambert, Sue, Lona, Tarjei, van Egmond, Teun, Naumetz, V., Ghent, Wesley, Cross, William W., Murdoch, Zoe

Volltext

Patients With Femoral Neck Fractures Are at Risk for Conversion to Arthroplasty After Internal Fixation: A Machine-learning Algorithm von van de Kuit, Anouk, Oosterhoff, Jacobien H F, Dijkstra, Hidde, Sprague, Sheila, Bzovsky, Sofia, Bhandari, Mohit, Swiontkowski, Marc, Schemitsch, Emil H, IJpma, Frank F A, Poolman, Rudolf W, Doornberg, Job N, Hendrickx, Laurent A M

Volltext

Factors Associated With Revision Surgery After Internal Fixation of Hip Fractures von Sprague, Sheila, Schemitsch, Emil H., Swiontkowski, Marc, Della Rocca, Gregory J., Jeray, Kyle J., Liew, Susan, Slobogean, Gerard P., Bzovsky, Sofia, Heels-Ansdell, Diane, Zhou, Qi, Bhandari, Mohit

Volltext

Arthroplasty Versus Internal Fixation for the Treatment of Undisplaced Femoral Neck Fractures: A Retrospective Cohort Study von Afaq, Shaikh, O'Hara, Nathan N., Schemitsch, Emil H., Bzovsky, Sofia, Sprague, Sheila, Poolman, Rudolf W., Frihagen, Frede, Heels-Ansdell, Diane, Bhandari, Mohit, Swiontkowski, Marc, Slobogean, Gerard P.

Volltext

Loss of Independence After Operative Management of Femoral Neck Fractures von Schemitsch, Emil H, Sprague, Sheila, Heetveld, Martin J, Bzovsky, Sofia, Heels-Ansdell, Diane, Zhou, Qi, Swiontkowski, Marc, Bhandari, Mohit

Volltext

Survival after neoadjuvant chemotherapy with or without bevacizumab or everolimus for HER2-negative primary breast cancer (GBG 44–GeparQuinto) von Minckwitz, G. von

Volltext bestellen

The FAITH and HEALTH Trials: Are We Studying Different Hip Fracture Patient Populations? von Blankstein, Michael, Schemitsch, Emil H., Bzovsky, Sofia, Axelrod, Daniel, Poolman, Rudolf W., Frihagen, Frede, Bhandari, Mohit, Swiontkowski, Marc, Sprague, Sheila, Schottel, Patrick C.

Volltext

Stabilization of the Trigonal High-Temperature Phase of Formamidinium Lead Iodide von Binek, Andreas, Hanusch, Fabian C, Docampo, Pablo, Bein, Thomas

Volltext